MyFinsight
Home
Blog
About
Contact
Download
Download image
The amount
represents proceeds from...
$7,190K
Proceeds from issuance of
common stock
$6,254K
Proceeds from warrant
exercises
$354K
Net cash provided by
(used in) financing...
$13,536K
Canceled cashflow
$262K
Cash, cash
equivalent, restricted...
$7,919K
Canceled cashflow
$5,617K
Issuance cost
$262K
Share-based compensation
$2,040K
Increase (decrease) in
accrued liabilities and...
$840K
Decrease (increase) in
accounts receivable
-$126K
Increase (decrease) in
accounts payable
$84K
Depreciation
$23K
Net cash provided by
(used in) operating...
-$5,537K
Net cash provided by
(used in) investing...
-$80K
Canceled cashflow
$3,113K
Net loss
-$8,423K
Purchase of property and
equipment
$80K
Increase in other current
assets
$219K
The amount of
finance income...
$8K
Back
Back
Cash Flow
source: myfinsight.com
Entera Bio Ltd. (ENTX)
Entera Bio Ltd. (ENTX)